Hepatitis F virus
From Wikipedia, the free encyclopedia
Hepatitis F is a hypothetical virus linked to hepatitis. Several hepatitis F candidates emerged in the 1990s; none of these reports have been substantiated.[1][2][3]
Most recently, in 1994 Deka et al reported that novel viral particles had been discovered in the stool of post-transfusion, non-hepatitis A, non-hepatitis B, non-hepatitis C, non-hepatitis E patients.[4] Injection of these particles, into the bloodstream of Indian rhesus monkeys caused hepatitis, and the virus was named hepatitis F, or Toga virus. Further investigations failed to confirm the existence of the virus, and it was delisted as a cause for infectious hepatitis.[3][5]
A subsequently-discovered virus thought to cause hepatitis was named hepatitis G, though its role in hepatitis has not been confirmed and it is now considered synonymous with GB virus C and is an "orphan virus" with no causal links to any human disease.[6]
[edit] References
- ^ Uchida T (1993). "Genetic variations of the hepatitis B virus and their clinical relevance". Microbiol Immunol 37 (6): 425–39. PMID 7694049.
- ^ Fagan EA (1994). "Acute liver failure of unknown pathogenesis: the hidden agenda". Hepatology 19 (5): 1307–12. PMID 8175156.
- ^ a b Bowden S (2001). "New hepatitis viruses: contenders and pretenders". J Gastroenterol Hepatol 16 (2): 124–31. doi: . PMID 11207890.
- ^ Deka N, Sharma MD, Mukerjee R (1994). "Isolation of the novel agent from human stool samples that is associated with sporadic non-A, non-B hepatitis". J Virol 68 (12): 7810–5. PMID 7966570.
- ^ Kelly D, Skidmore S (2002). "Hepatitis C-Z: recent advances". Arch Dis Child 86 (5): 339–43. doi: . PMID 11970925.
- ^ Lefrère JJ, Laperche S, Roudot-Thoraval F (April 2008). "Hepatitis G virus: a suitable marker of in vivo efficacy for pathogen inactivation". Vox Sang.. doi: . PMID 18393946.